Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Moon Lake Immunotherapeutics Transaction History
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.
- $485 Billion
- Q1 2025
A detailed history of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 85 shares of MLTX stock, worth $4,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85
Previous 85
-0.0%
Holding current value
$4,155
Previous $4.6 Million
27.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MLTX
# of Institutions
161Shares Held
55.2MCall Options Held
481KPut Options Held
229K-
Bvf Inc San Francisco, CA19.8MShares$966 Million33.91% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$415 Million35.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.97MShares$145 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$135 Million1.75% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.48MShares$72.3 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.81B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...